Monopar Therapeutics Inc.
Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. Its lead product candidate in development is Validive, a clonidine hydrochloride mucobuccal tablet…
Biotechnology
US, Wilmette [HQ]
Lobbying Analysis
Lobbying · US Senate · Influence
Monopar Therapeutics Inc. has no lobbying expenses in our database.
History
DownloadFY | Quarter | Expense For Lobby Disclosure | LDA Reference |
---|---|---|---|
No data |